These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15686451)

  • 1. Lysosomal storage disorders.
    Vellodi A
    Br J Haematol; 2005 Feb; 128(4):413-31. PubMed ID: 15686451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal storage disease: revealing lysosomal function and physiology.
    Parkinson-Lawrence EJ; Shandala T; Prodoehl M; Plew R; Borlace GN; Brooks DA
    Physiology (Bethesda); 2010 Apr; 25(2):102-15. PubMed ID: 20430954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular pathology of lysosomal diseases.
    Cox TM; Cachón-González MB
    J Pathol; 2012 Jan; 226(2):241-54. PubMed ID: 21990005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Ranieri E; Ravenscroft EM; Hua CT; Brooks DA; Hopwood JJ
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():104-10. PubMed ID: 11400743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Curr Opin Mol Ther; 2001 Aug; 3(4):399-406. PubMed ID: 11525564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the biochemistry and genetics of sphingolipidoses.
    Ozkara HA
    Brain Dev; 2004 Dec; 26(8):497-505. PubMed ID: 15533650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysosomal storage diseases - update and new therapeutic options].
    Schöpfer K; Miebach E; Beck M; Pitz S
    Klin Monbl Augenheilkd; 2011 Feb; 228(2):144-60. PubMed ID: 20309790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care.
    Wilcox WR
    J Pediatr; 2004 May; 144(5 Suppl):S3-14. PubMed ID: 15126978
    [No Abstract]   [Full Text] [Related]  

  • 13. Mass spectrometry in the study of lysosomal storage disorders.
    Meikle PJ; Fuller M; Hopwood JJ
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):769-77. PubMed ID: 14528914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome.
    Walkley SU
    Acta Paediatr; 2007 Apr; 96(455):26-32. PubMed ID: 17391436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage solutions: treating lysosomal disorders of the brain.
    Jeyakumar M; Dwek RA; Butters TD; Platt FM
    Nat Rev Neurosci; 2005 Sep; 6(9):713-25. PubMed ID: 16049428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
    Virta S; Rapola J; Jalanko A; Laine M
    J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles.
    Reuser AJ; Drost MR
    Acta Paediatr Suppl; 2006 Apr; 95(451):77-82. PubMed ID: 16720471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potentially dynamic lysosomal role for the endogenous TRPML proteins.
    Zeevi DA; Frumkin A; Offen-Glasner V; Kogot-Levin A; Bach G
    J Pathol; 2009 Oct; 219(2):153-62. PubMed ID: 19557826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS.
    Giugliani R; Vairo F; Kubaski F; Poswar F; Riegel M; Baldo G; Saute JA
    Lancet Child Adolesc Health; 2018 Jan; 2(1):56-68. PubMed ID: 30169196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.